Srinagar: With the fresh surge of 60,975 COVID infections, tally in India has mounted to 31,67,323.
According to a report by Health Ministry of India, the number of fatalities linked to the outbreak rose to 58,390 after 848 deaths were recorded in the last 24 hours.
A total of 66,550 patients recovered on Monday – the highest in a day – taking the total number of recoveries to 24,05,585. The recovery rate stood at 75.91 per cent this morning.
Currently, there are over 150 coronavirus vaccines in various stages of development in several countries with a few making advanced progress in clinical trials.
Earlier, Russia announced that the country has already produced the first batch of its COVID vaccine.
In India, a Pune based vaccine manufacturer, the Serum Institute of India (SII) has decided to manufacture 100 million COVID vaccine doses which will be capped at Rs 225 per dose.
While the Oxford coronavirus vaccine and a Chinese vaccine showing positive results in the first round of human trials, the Moderna has shown positive results among mice and developed immunity against the disease upon testing.
India’s Covaxin, developed by Hyderabad-based Bharat Biotech has also entered the human trial stage and is expected to come out with results in a month.
Pertinently, on August 15, the Prime Minister of India said that three probable COVID vaccines are currently being developed in India and large-scale production will begin as soon as scientists give a green signal.
The Prime Minister paid tribute to all the frontline workers involved in India’s fight against the pandemic.
However, the World Health Organisation (WHO) has warned world governments against “vaccine nationalism” and urged leaders to make plans on how to share life-saving inoculations against coronavirus.
WHO Director-General Dr Tedros Adhanom Ghebreyesus said the threat of COVID can only be snuffed out with global coordination, especially when a vaccine is developed.
Free Press Kashmir is now on Telegram. Click here to Join.
